SpaceX stock closed within 3% of its $112 initial public offering price on Friday, erasing most of the first-week rally that briefly lifted the company to a $365 billion market capitalization. The round-trip took eleven trading days. The repricing forces a question allocators hoped to defer: whether Musk's refusal to follow standard IPO convention was vision or hubris, and whether the floor holds.
The offering priced on April 14th with atypical structure—founders retained dual-class control, no traditional roadshow, and a non-traditional allocation process that prioritized retail and existing Starlink customers over institutional anchor orders. First-week enthusiasm pushed shares to $147 by April 21st, a 31% pop that looked like validation. By May 2nd, the stock had surrendered the entire gain and then some, touching $109 intraday before a late-session bounce. Volume in week two ran 4.2x the IPO week average, with block trades accounting for 38% of flow—a sign that early institutional holders were repricing risk faster than the crowd.
The issue is not revenue clarity. Starlink alone generated an estimated $6.8 billion in 2024 subscriber revenue, and launch contracts with NASA and the Department of Defense provide $4.1 billion in visible backlog through 2027. The issue is whether a $350 billion valuation—51x trailing revenue, 94x estimated EBITDA—leaves room for the next decade of Starship development, Mars architecture, and the regulatory gauntlet that comes with both. Allocators who modeled a 15% discount rate are now testing 18% and watching the denominator compress future cash flows by a third. The Starlink comps—Iridium, Viasat, OneWeb—trade between 1.2x and 3.4x revenue; SpaceX priced at a frontier multiple that assumed zero execution risk and infinite regulatory patience.
What separates this from standard IPO volatility is the absence of a stabilization mechanism. Traditional offerings include a greenshoe option and a syndicate desk committed to price support for thirty days. SpaceX dispensed with both. There is no underwriter buying the dip, no over-allotment buffer. The stock trades on its own tension between Musk's track record and the arithmetic of a $350 billion starting line. For family offices and funds that took the IPO allocation, the decision tree is narrow: the thesis was either correct at $112 and remains correct now, or it was never correct and the first-week pop was the exit. There is no in-between at this valuation.
Allocators should watch three near-term catalysts. First, the Q1 earnings call, tentatively scheduled for May 14th, will be the first public discussion of Starlink unit economics and Starship development burn rate. Second, the FCC's pending decision on additional Starlink orbital slots, expected by late May, will either expand the addressable market or cap it. Third, the expiration of the 180-day lock-up on insider and employee shares in mid-October will test whether the current shareholder base was built for duration or liquidity. If the stock is still near $112 in October, that lock-up expiration will clarify intent.
The 24% decline is not the story. The story is that $112 was the number Musk chose, and the market is now deciding whether it was a floor or a ceiling dressed as a floor.